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Background: The recent emergence of several high sensitivity troponin (hsTroponin) assays has shown that cardiac troponins can be chronically 
elevated in response to cardiovascular comorbidities and that they confer important prognostic information. In the absence of unstable coronary 
artery disease, pathophysiological mechanisms as increased demand ischemia or disturbances of cardiomyocite cell membrane integrity are 
possible causes for troponin leakage. We hypothesized tha with a high sensitivity assay; troponin level would be higher in diabetic patients with 
coronary artery disease (CAD), in comparison to diabetic patients without coronary artery disease. Our objective was to hsTroponin levels in diabetic 
patients with multivessel CAD and diabetic patients with angiographically normal coronary arteries.
methods: Hs troponin levels were determinated in 85 diabetic patients: 51 women (22 with CAD and 29 with normal coronary arteries) and 44 
men (34 with CAD and 10 with normal coronary arteries). Patients were paired by age and body mass index. Both groups of patients had preserved 
left ventricular function measured by ventriculography or echocardiography. Patients with atrial fibrillation, left ventricular hypertrophy or chronic 
kidney disease were excluded.
results: hsTroponin levels were significantly higher (P=0.0005) in diabetic women with CAD (average= 12.95±5.55 pg/mL) in comparison to 
diabetic women with normal coronary arteries (average= 8.02±2.62 pg/mL). hsTroponin levels were also significantly higher(P=0.0086) in diabetic 
men with CAD (average= 10.60±4.39 pg/mL) in comparison to diabetic men with normal coronary arteries (average= 6.94±1.67). At a troponin 
cutoff of 11 pg/mL 90% of diabetic men and 75% of diabetic women had CAD.
conclusion: In this study hsTroponin I was a strong marker of CAD in diabetic patients with multivessel CAD in comparison with diabetic patients 
with angiographically normal coronary arteries. hsTroponin may help to stratify risk of CAD among diabetic patients with normal ventricular function. 
The discriminating power was higher among men.
